Aurisco Pharmaceutical (605116.SS) Earnings Analysis
Aurisco Pharmaceutical (605116.SS) has no confirmed upcoming earnings date. Trailing P/E 19.90.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 605116.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 605116.SS. This page updates as the calendar is published.
605116.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 0.16 CNY | n/a | n/a | n/a |
| 2026-04-16 | 0.23 CNY | n/a | n/a | n/a |
| 2025-10-31 | 0.2949 CNY | n/a | n/a | n/a |
| 2025-04-25 | 0.1782 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.3 CNY | n/a | n/a | n/a |
| 2024-10-24 | 0.2368 CNY | n/a | n/a | n/a |
| 2024-08-28 | 0.2647 CNY | n/a | n/a | n/a |
605116.SS valuation and analyst view
| Trailing P/E | 19.90 |
|---|---|
| Trailing EPS | 0.98542 CNY |
| Price / book | 2.81 |
| Dividend yield | 1.78% |
| Market cap | 7.86B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Aurisco Pharmaceutical (605116.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 605116.SS. This page updates as the calendar is published.
Did 605116.SS beat earnings last quarter?
Consensus estimate data was not available for 605116.SS's 2026-04-23 report.
What is 605116.SS's current P/E ratio and EPS?
605116.SS trades at a trailing P/E of 19.90 on trailing EPS of 0.9854235063044098 CNY.
What do analysts rate 605116.SS?
605116.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.